Stretch Mark Treatment
For stretch marks (striae distensae), I recommend combination therapy with fractional CO2 laser plus platelet-rich plasma (PRP) as the most effective treatment, with topical tretinoin 0.1% as a reasonable alternative for early striae rubra when laser therapy is not accessible. 1
Treatment Algorithm by Striae Type and Patient Status
For Non-Pregnant, Non-Nursing Patients
Striae Rubra (Red/Recent Stretch Marks):
- First-line: Fractional CO2 laser combined with intradermal PRP injections (3 sessions at 6-week intervals)
- This combination shows superior outcomes with 60.33% achieving excellent improvement versus laser alone
- Histologically demonstrates increased collagen and elastin fiber deposition 1
- Alternative: Topical tretinoin 0.1% cream applied daily for 3 months
- Shows 20% reduction in lesion length with significant global improvement 2
- More effective in early striae rubra than established striae alba
Striae Alba (White/Mature Stretch Marks):
- First-line: Fractional CO2 laser + PRP (superior to other combinations) 1
- Second-line: Microneedling with PRP (3 sessions at 1-month intervals)
- Shows statistically significant collagen and elastin deposition versus microneedling alone 1
- Third-line: Intradermal radiofrequency plus PRP (3 sessions at 4-week intervals)
- 63.2% patient satisfaction with "satisfied" or "very satisfied" ratings 1
For Pregnant or Nursing Patients
Topical retinoids (tretinoin, adapalene, tazarotene) are absolutely contraindicated during pregnancy and nursing due to teratogenicity. 3, 4
Safe Options:
- Silicone-based formulations with hyaluronic acid and vitamin C
- Applied twice daily for at least 1 month
- 86.4% reported improved texture and appearance with 90.9% reporting no tolerability issues 5
- Hyaluronic acid moisturizers alone
- Safe throughout pregnancy and nursing
- Provides modest improvement in skin texture
Defer until after pregnancy/nursing:
- All laser therapies
- PRP injections
- Microneedling procedures
- Topical tretinoin (wait until completely finished nursing)
Key Clinical Considerations
Timing Matters:
- Earlier treatment yields better results across all modalities 1, 6, 7
- Striae rubra respond more favorably than striae alba to all treatments 6, 8
- Most patients notice visible improvement within 2 weeks of starting effective treatment 7
Skin Type Considerations:
- Darker skin types (Fitzpatrick IV-VI) have higher risk of post-inflammatory hyperpigmentation with ablative lasers
- Non-ablative fractional lasers (1565 nm) show better tolerability in darker skin 6, 9
- Medium skin tones report greater satisfaction than very fair or very dark skin 7
Patient Factors Affecting Outcomes:
- Younger patients (≤44 years) achieve higher satisfaction rates 7
- Smoking negatively impacts treatment outcomes 7
- Newer striae consistently show better response than older lesions 7
Common Pitfalls to Avoid
Do not use topical retinoids in pregnancy/nursing - highly teratogenic risk that persists throughout pregnancy and into breastfeeding 3, 4
Do not rely on monotherapy for striae alba - combination approaches consistently outperform single modalities, with fractional CO2 + PRP showing the strongest evidence 1
Do not expect complete clearance - even the best treatments (CO2 laser + PRP) show only 4% complete response rates for striae alba, though 31% for striae rubra with PRP injections 8
Do not use silicone gel sheeting as primary therapy - while safe, evidence shows silicone-based topical formulations with growth factors are more effective than sheeting alone 5
Evidence Quality Notes
The 2025 guideline on autologous platelet concentrates 1 provides the most recent and comprehensive evidence, though it acknowledges that "clinical trials on APCs and their effect on striae distensae are scarce and their level of evidence mostly poor." The combination of fractional CO2 laser with PRP consistently demonstrates both clinical and histopathological improvement across multiple studies. For pregnant patients, the teratogenicity warnings come from high-quality guidelines on acute promyelocytic leukemia management 3, 4, which explicitly state retinoids "are highly teratogenic and should be avoided in the first trimester" and throughout pregnancy.